Imaging by 4 DFlow in Patients With Tetralogy of Fallot

NCT ID: NCT03542968

Last Updated: 2020-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-10-12

Study Completion Date

2020-04-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Conventionnal cadiac magnetic resonance (CMR) is the reference to assess changes in right heart flow and pulmonary artery hemodynamics in patients with repaired Tetralogy of Fallot.

4D Flow CMR Imaging is a new imaging modality able to assess all of these parameters faster (8 min vs 30 min) and more comfortably.

The aim of this study is to compare conventionnal CMR and 4D Flow CMR for the assessment of these parameters (ventricular volume, ventricular systolic function, and regurgitation of the pulmonary pathway).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Congenital heart disease, or corrected heart disease requires regular, specialized follow-up throughout the life of these patients. Among the recommended examinations, cardiac MRI is the reference for functionnal ventricles assessment (volume/systolic function), particularly for the right ventricle.

Among these pathologies, the tetralogy of Fallot is indicative of the increasing importance of cardiac MRI. In this disease, strong parameters has been identifies for the follow to prevent right ventricle dysfunction and ventricular arrhythmias. They rely on right ventricle volumes and on the pulmonary artery regurgitation, both using cardiac MRI.

However, this imaging modality imposes constraints such as a long acquisition times (30 to 40 min) or the need to hold apneas, which may render the procedure uncomfortable, even more in the case of very young patients.

The idea of exploring a new imaging modality is therefore based on the willingness to offer a faster and more comfortable examination. 4D Flow MRI could enable conventionnal parameters, detection of both normal and abnormal right heart flow patterns, and may allow comprehensive analysis of post-surgically altered geometries and hemodynamics.

4D Flow MRI cardiac imaging is :

* A single and faster acquisition (8 to 15 minutes) that cardiac MRI.
* A free breathing acquisition Imaging modality.
* A quite-isotropic assessment.
* A technically simple exam (a single sequence requiring low competence).
* And offers unlimited post processing.

The investigators hypothesize that 4D MRI is non-inferior to 2D MRI in patients with corrected tetralogy of Fallot, for the evaluation of conventional cardiac evaluation parameters: ventricular volume, ventricular systolic function, and regurgitation of the pulmonary pathway.

The investigators hypothesize that 4D MRI is superior to 2D MRI in patients with corrected tetralogy of Fallot, as ti allows to identifying new predictors of ventricular dysfunction such as intravenous extracardiac turbulent / laminar flow character, preferential orientation, flow distribution and trans-tricuspid diastolic flow.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Heart Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

4D magnetic resonance imaging

MRI, 4D imaging, acquisition and analysis of 4D cardiac MRI images-A single, faster acquisition (8 to 15 minutes).

Group Type EXPERIMENTAL

magnetic resonance imaging

Intervention Type PROCEDURE

Acquisition 4D Flow magnetic resonance Imaging-8 minutes

2D magnetic resonance imaging

MRI, 2D imaging, acquisition and analysis of 2D cardiac MRI

Group Type SHAM_COMPARATOR

magnetic resonance imaging

Intervention Type PROCEDURE

Acquisition 4D Flow magnetic resonance Imaging-8 minutes

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

magnetic resonance imaging

Acquisition 4D Flow magnetic resonance Imaging-8 minutes

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* \- children from the age of 10 and above without any upper age limit;
* giving their informed consent for the study;
* with a corrected tetralogy of Fallot;
* sent for a follow-up imaging examination with endomyocardial fibrosis screening;

Exclusion Criteria

* \- pregnant woman;
* children \<10 years old;
* All contraindications inherent to MRI: (claustrophobia, ferromagnetic intracorporeal foreign bodies)
* Contraindication to contrast media injection (Gadolinium)
Minimum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Chirurgical Marie Lannelongue

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Marc Antoine ISORNI, Doctor

Role: PRINCIPAL_INVESTIGATOR

Hôpital Marie Lannelongue

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Marie Lannelongue

Le Plessis-Robinson, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Olaf Mercier, Professor

Role: CONTACT

+33140948695

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Marc antoine ISORNI

Role: primary

+33140948554

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A01482-51

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Radiation-Free Heart Catheterization Using MRI
NCT02739087 ACTIVE_NOT_RECRUITING NA
Accelerated Stress CMR in Coronary Artery Disease
NCT05221762 ACTIVE_NOT_RECRUITING